Swedish Orphan Biovitrum AB (SWOBY)
22.16
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Swedish Orphan Biovitrum Enterprise Value : 17.10B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 17.10B |
| October 07, 2026 | 17.10B |
| October 06, 2026 | 17.10B |
| October 05, 2026 | 17.10B |
| October 02, 2026 | 17.10B |
| October 01, 2026 | 17.10B |
| September 30, 2026 | 17.30B |
| September 29, 2026 | 16.08B |
| September 28, 2026 | 16.08B |
| September 25, 2026 | 16.08B |
| September 24, 2026 | 16.66B |
| September 23, 2026 | 16.66B |
| September 22, 2026 | 16.47B |
| September 21, 2026 | 16.89B |
| September 18, 2026 | 16.26B |
| September 17, 2026 | 16.26B |
| September 16, 2026 | 16.26B |
| September 15, 2026 | 16.44B |
| September 14, 2026 | 17.68B |
| September 11, 2026 | 18.58B |
| September 10, 2026 | 18.58B |
| September 09, 2026 | 18.58B |
| September 08, 2026 | 18.58B |
| September 04, 2026 | 18.58B |
| September 03, 2026 | 18.58B |
| Date | Value |
|---|---|
| September 02, 2026 | 18.58B |
| September 01, 2026 | 19.76B |
| August 31, 2026 | 19.76B |
| August 28, 2026 | 19.76B |
| August 27, 2026 | 19.76B |
| August 26, 2026 | 18.59B |
| August 25, 2026 | 18.59B |
| August 24, 2026 | 18.59B |
| August 21, 2026 | 18.59B |
| August 20, 2026 | 18.59B |
| August 19, 2026 | 18.59B |
| August 18, 2026 | 18.59B |
| August 17, 2026 | 18.59B |
| August 14, 2026 | 18.59B |
| August 13, 2026 | 18.59B |
| August 12, 2026 | 18.59B |
| August 11, 2026 | 18.59B |
| August 10, 2026 | 18.59B |
| August 07, 2026 | 18.59B |
| August 06, 2026 | 17.85B |
| August 05, 2026 | 17.85B |
| August 04, 2026 | 17.85B |
| August 03, 2026 | 17.92B |
| July 31, 2026 | 17.92B |
| July 30, 2026 | 18.03B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hansa Biopharma AB | 377.72M |
| BioArctic AB | 2.416B |
| Diamyd Medical AB | 81.42M |
| BONESUPPORT HOLDING AB | 1.462B |
| BioInvent International AB | 183.41M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 117.25M |
| Revenue (Quarterly) | 837.43M |
| Total Expenses (Quarterly) | 720.28M |
| EPS Diluted (Quarterly) | 0.1673 |
| Gross Profit Margin (Quarterly) | 61.17% |
| Profit Margin (Quarterly) | 14.00% |
| Earnings Yield | 0.98% |
| Operating Earnings Yield | 6.38% |
| Normalized Earnings Yield | 4.494 |